0001062993-22-007007.txt : 20220307
0001062993-22-007007.hdr.sgml : 20220307
20220307184648
ACCESSION NUMBER: 0001062993-22-007007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220303
FILED AS OF DATE: 20220307
DATE AS OF CHANGE: 20220307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peterson Kristine
CENTRAL INDEX KEY: 0001508596
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35839
FILM NUMBER: 22719778
MAIL ADDRESS:
STREET 1: AMARIN CORPORATION
STREET 2: MYSTIC PACKER BLDG., 12 ROOSEVELT AVENUE
CITY: MYSTIC
STATE: CT
ZIP: 06355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENANTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001177648
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 500 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617 607 0800
MAIL ADDRESS:
STREET 1: 500 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-03-03
0001177648
ENANTA PHARMACEUTICALS INC
ENTA
0001508596
Peterson Kristine
C/O ENANTA PHARMACEUTICALS, INC.
500 ARSENAL STREET
WATERTOWN
MA
02472
1
0
0
0
Stock Option (right to buy)
68.22
2022-03-03
4
A
0
7500
0
A
2032-03-03
Common Stock
7500
7500
D
Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 3, 2022), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2023 annual meeting of stockholders.
/s/ Nathaniel S. Gardiner as attorney-in-fact
2022-03-07